À propos de ce poste Senior Director, Real World Evidence & Health Economics and Outcomes chez Lexeotx
Role Summary
The Senior Director, Real World Evidence and Health Economics and Outcomes, is responsible for providing scientific input during protocol development, study design, oversight of clinical aspects of study conduct, and interpretation of study results through the final study report. The candidate will also be responsible for establishing rigorous assessment of real world data to assess the natural history of diseases and real world outcomes for LEXEO’s early development and clinical portfolio. The Senior Director, Real World Evidence and Health Economics and Outcomes will work closely with other members of the clinical development and operations teams, and relevant internal stakeholders to execute and deliver milestones. The successful candidate will be highly collaborative and motivated, with excellent knowledge of first-in-human clinical trial design, preferably with experience in gene or cell therapy, and experience developing RWE historical control and methods. The candidate must also possess excellent leadership, communication, and organizational skills, be solution-oriented, exhibit high attention to detail and quality, and have strong initiative and execution to timelines.
If you enjoy being a part of a growing team and an entrepreneurial environment in which your work will have a meaningful impact on clinical trial progress for novel gene therapies, we want to hear from you!
Primary Responsibilities
Required Skills and Qualifications
About LEXEO
LEXEO Therapeutics is a clinical-stage genetic medicine company headquartered in New York City, pioneering cardiac genetic medicine candidates to treat the root causes of inherited cardiovascular diseases. Our lead program, LX2006, targets cardiomyopathy associated with Friedreich’s Ataxia and anchors a broader pipeline addressing genetically defined conditions such as hypertrophic and arrhythmogenic cardiomyopathies. Backed by a strong financial foundation, LEXEO is positioned to translate groundbreaking science into durable clinical impact.
Our work culture is a hybrid model with 2 days/week in the New York City office and 3 days working from home.
LEXEO Therapeutics is an EEO employer committed to an exciting, diverse, and enriching work environment.